Cost-effective PHA biopolymer production from locally generated brewer's spent grain using mixed microbial fermentation. Builds on demonstrated cellulose-based biocomposites with 19% lower carbon footprint than PET, targeting food-contact applications with full regulatory compliance.
This research program addresses the high cost barriers in current biopolymer production by developing non-sterile, mixed microbial fermentation processes to convert brewer's spent grain into polyhydroxyalkanoates (PHA). Brewer's spent grain is a high-volume, low-cost waste stream from brewing operations, making it an attractive feedstock for sustainable biopolymer manufacturing. The work builds on prior demonstration of compostable cellulose-based multilayer materials using agricultural waste, which achieved a 19% reduction in carbon footprint compared to PET and exhibited strong barrier properties suitable for packaging applications.
The solution targets food-contact packaging and other applications where compostable, high-performance biocomposites are needed. By integrating locally sourced waste feedstocks with simplified fermentation processes, the approach aims to achieve cost parity with conventional plastics while delivering environmental benefits.
Feedstock and process innovation:
Prior material achievements:
Downstream processing and validation:
The underlying cellulose recovery and biocomposite processing capabilities have been validated through feedstock availability assessments, methodology development for biopolymer building block recovery, and processing on industrial production infrastructure into multilayer sheets and thermoformed products. The PHA production from spent grain is currently at an optimization stage, with planned three-stage microbial selection trials, downstream process development, and comprehensive characterization and regulatory testing to demonstrate consistent industrial quality and end-of-life performance.
Queen’s University Belfast is a comprehensive public research university in Northern Ireland with a strong industry-facing culture. Co-located laboratories at the Institute of Electronics, Communications and Information Technology (ECIT) sit within the Titanic Quarter alongside the Catalyst science park, giving partners direct access to talent, testbeds, and startups. Clinical research facilities embedded within Belfast City Hospital, and the iREACH Health development, enable streamlined trials and translation with the Belfast Health and Social Care Trust. Research is supported by competitive funding from UK Research and Innovation councils, Innovate UK, and European programs. Commercialization is enabled by a dedicated technology transfer office and QUBIS Ltd, supporting licensing and spin-out creation.